Cancers, Vol. 15, Pages 3917: Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
Cancers, Vol. 15, Pages 3917: Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
Cancers doi: 10.3390/cancers15153917
Authors:
Felix Johnson
Benedikt Hofauer
Markus Wirth
Barbara Wollenberg
Fabian Stögbauer
Susan Notohamiprodjo
Bernhard Haller
Robin Reschke
Andreas Knopf
Ulrich Strassen
Reliable preoperative diagnosis between salivary gland tumor entities is difficult. In this monocentric retrospective study, we examined the somatostatin receptor 2 (SSTR2) status of salivary gland tumors after salivary gland tumor resection via immunohistochemistry (IHC), and stains were compared in analogy to the HER2 mamma scale. A total of 42.3% of all pleomorphic adenoma (PA) tumors (42 of 99, 95% confidence interval 32.5–52.8%) demonstrated ≥20% of cells displaying the SSTR2 as compared to just 1% of all other tumors (1/160, 95% CI 0.02–3.4%). The other tumor was a neuroendocrine carcinoma. PA had a higher intensity of SSTR2 staining, with 90.9% staining ≥ an intensity of 2 (moderate). Tumors with an intensity of SSTR2 expression equal to or greater than 2 had an 89.9% likelihood of being a PA (95% CI: 82.2–95.0%, AUC: 0.928). Only one Warthin tumor demonstrated a ‘strong’ SSTR2 staining intensity. No Warthin tumor showed a percentage of cells staining for SSTR2 above ≥...
Source: Cancers - Category: Cancer & Oncology Authors: Felix Johnson Benedikt Hofauer Markus Wirth Barbara Wollenberg Fabian St ögbauer Susan Notohamiprodjo Bernhard Haller Robin Reschke Andreas Knopf Ulrich Strassen Tags: Article Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | HER2 | Neurology | Study | Warthin's Tumor